Dendreon
Thursday Options Brief: ATVI, DNDN, HIG, DD, RCL, SFD & AMR
...represent a whopping 32.28% of total existing open interest on the stock of 158,517 lots. Dendreon Corp. (DNDN) - A bear with butterfly wings feasted on the biotechnology company's...
The Best Stock Under $5
...be suggesting this ride up can continue in a significant way ($5+). The stock reminds me of Dendreon (DNDN), which hung out in the $2-5 range before jumping into the $20s on a good...
JavaScript and Flash are required to fully enjoy Evri
Cell Therapeutics' Friday Bonuses, Dendreon's IT Partner, Lee Hood's Eye on South Lake Union, & More Seattle-Area Life Sciences News
...round of cash bonuses, while life for its shareholders hasn't been so hot. -Seattle-based Dendreon (NASDAQ: DNDN) has very little margin for error in the IT system that it needs to keep...
Dendreon stock mauling probed by regulators
By Matthew Goldstein A lightening fast sell-off of shares of biotech company Dendreon <DNDN.O> last April is drawing scrutiny from U.S. securities regulators and the independent monitor...
Dendreon Leans on California 9-1-1 Software Vendor to Keep Provenge Trains on Time
...from talking to Wud Pocinwong, a senior vice president with Direct Technology in Bellevue. Dendreon (NASDAQ: DNDN) has made headlines for years with its first-of-a-kind treatment...
Investors Show Confidence in Dendreon
by: EP Vantage March 07, 2010 | about: DNDN It has been a good week for Dendreon (DNDN). First, the FDA, prodded by rumours to the contrary, announced that it had not scheduled another...
Cloudmark, Vulcan, Zuckerberg, thePlatform, Dendreon and more
...of online advertising. TechFlash > Venture Blog > 2010 > March > Cloudmark, Vulcan, Zuckerberg, thePlatform, Dendreon and more Cloudmark, Vulcan, Zuckerberg, thePlatform, Dendreon...
Dendreon's False Rumor, Cell Therapeutics' New FDA Day, Microsoft's Health-IT Plan, & More Seattle-Area Life Sciences News
...drugs attracted a ton of interest in Seattle biotech this week. -Seattle-based Dendreon (NASDAQ: DNDN) lived up to its nickname on Wall Street this week: Dendrama. The company was...
"It's an indication of the trust that Dendreon has in the skills we have in supporting their business," Pocinwong says.
Dendreon Leans on California 9-1-1 Software Vendor to Keep Provenge Trains on Time Xconomy | 1 week ago
Dendreon Follow-Up Confirms Survival Edge, Helping Fend off Sanofi Rival
...Genitourinary Cancers Symposium in San Francisco. Those following the Dendreon story know that the survival advantage enabled the company to raise more than $600 million last year,...
Dendreon stock rises 2.3%; FDA says no meeting on Provenge
Shares of biotechnology company Dendreon jumped Tuesday after federal regulators said they don't plan to hold a public meeting on the company's prostate cancer treatment, possibly leading...
Dendreon, The FDA And A False Alarm
...with some docs, who claimed to be invited to such a meeting, according to TheStreet.com. The news sent Dendreon stock down about 5 percent and set off a scramble to ascertain the truth.
Dendreon Fluctuates On FDA Rumors
...trade, we will make an 11.1% return in three months as long as DNDN is above $17.50 at May expiration. Dendreon would have to fall by more than 49% before we would start to lose...
